NCT00492440View on ClinicalTrials.gov

Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer

PHASE1TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

July 31, 2010

Study Completion Date

December 31, 2010

Conditions
Kidney CancerMelanoma (Skin)
Interventions
BIOLOGICAL

recombinant interleukin-7

GENETIC

gene expression analysis

GENETIC

polymerase chain reaction

GENETIC

protein expression analysis

OTHER

flow cytometry

OTHER

immunoenzyme technique

OTHER

immunologic technique

OTHER

laboratory biomarker analysis

OTHER

pharmacological study

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda

Sponsors

Lead Sponsor

Cytheris SA

Collaborators (1)

Cytheris, Inc.
All Listed Sponsors
collaborator

Cytheris, Inc.

INDUSTRY

lead

Cytheris SA

INDUSTRY

NCT00492440 - Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer | Biotech Hunter | Biotech Hunter